BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17345841)

  • 21. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
    Ławicki S; Będkowska GE; Wojtukiewicz M; Szmitkowski M
    Adv Med Sci; 2013; 58(2):207-15. PubMed ID: 23846151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma macrophage colony-stimulating factor, granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor levels in continuous ambulatory peritoneal dialysis patients].
    Saionji K; Hamada T; Higurashi H; Shimizu T; Hukuromoto T; Takeshima S; Kurotani W
    Rinsho Byori; 1997 May; 45(5):493-7. PubMed ID: 9170979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors.
    Ławicki S; Czygier M; Bedkowska E; Wojtukiewicz M; Szmitkowski M
    Pol Arch Med Wewn; 2008 Sep; 118(9):464-9. PubMed ID: 18846980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
    Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
    Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker].
    Zeimet AG; Guadagni F; Marth C; Amato T; Müller-Holzner E; Huter O; Daxenbichler G; Dapunt O
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):195-9. PubMed ID: 7789707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Prontera C; Facchini V; Bianchi R; Genazzani AR
    Gynecol Oncol; 1998 Jul; 70(1):111-4. PubMed ID: 9698485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in breast cancer patients after surgery].
    Czygier M; Ławicki S; Szmitkowski M
    Przegl Lek; 2009; 66(8):433-6. PubMed ID: 20043590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential alterations in plasma colony-stimulating factor concentrations after coronary artery bypass graft surgery with extracorporeal circulation.
    Denizot Y; Karoutsos S; Nathan N
    Cytokine; 2001 Mar; 13(5):314-6. PubMed ID: 11243710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Macrophage colony-stimulating factor (M-CSF) as a candidate for the tumor marker of breast cancer].
    Ławicki S; Mroczko B; Omyła J; Czygier M; Szmitkowski M
    Pol Arch Med Wewn; 2003 Jun; 109(6):597-602. PubMed ID: 14582473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].
    Takeyama H; Kajiguchi T; Miyata Y; Saito M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):873-8. PubMed ID: 10897214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in gynecological cancer patients].
    Czygier M; Ławicki S; Gacuta-Szumarska E; Bedkowska E; Szmitkowski M
    Przegl Lek; 2010; 67(3):184-6. PubMed ID: 20687382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy.
    Corbacioglu S; Bux J; König A; Gabrilove JL; Welte K; Bussel JB
    J Pediatr; 2000 Jul; 137(1):96-9. PubMed ID: 10891829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma granulocyte-macrophage colony stimulating factor (GM-CSF) and activity of enzymes in granulocytes of breast cancer patients].
    Czygier M; Ławicki S; Szmitkowski M; Mroczko B
    Przegl Lek; 2006; 63(8):654-7. PubMed ID: 17441377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.